What analyst predict for Johnson & Johnson NYSE:JNJ?


What analyst predict for Johnson & Johnson NYSE:JNJ?

Johnson & Johnson NYSE:JNJ headquartered in New Brunswick, New Jersey, United States is reporting their earnings on 07/17/2018 before the bell. Street forecast for the quarter ending March 2018 is $2.06.

According to stock market daily analyst this is Lower then same time previous year. Johnson & Johnson, reported EPS for the same quarter last year was $1.83.



Overview of Johnson & Johnson NYSE:JNJ

Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500.

Johnson & Johnson is headquartered in New Brunswick, New Jersey, the consumer division being located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in 60 countries and products sold in over 175 countries. Johnson & Johnson had worldwide sales of $70.1 billion during calendar year 2015.The company has made the 3rd largest pharmaceutical settlement with the U.S. Department of Justice.

% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Dividend Rate